969 related articles for article (PubMed ID: 12875981)
1. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression.
Li Y; Spataro BC; Yang J; Dai C; Liu Y
Kidney Int; 2005 Oct; 68(4):1500-10. PubMed ID: 16164627
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF.
Dai C; Liu Y
J Am Soc Nephrol; 2004 Jun; 15(6):1402-12. PubMed ID: 15153551
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression.
Li L; He D; Yang J; Wang X
J Pharmacol Sci; 2011; 117(4):286-94. PubMed ID: 22134049
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.
Kobayashi E; Sasamura H; Mifune M; Shimizu-Hirota R; Kuroda M; Hayashi M; Saruta T
Kidney Int; 2003 Oct; 64(4):1179-88. PubMed ID: 12969135
[TBL] [Abstract][Full Text] [Related]
7. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts.
Suzuki H; Uchida K; Nitta K; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895
[TBL] [Abstract][Full Text] [Related]
8. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
9. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
Yang J; Liu Y
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
[TBL] [Abstract][Full Text] [Related]
10. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
[TBL] [Abstract][Full Text] [Related]
11. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
[TBL] [Abstract][Full Text] [Related]
12. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
13. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
[TBL] [Abstract][Full Text] [Related]
14. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
16. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
Rhyu DY; Yang Y; Ha H; Lee GT; Song JS; Uh ST; Lee HB
J Am Soc Nephrol; 2005 Mar; 16(3):667-75. PubMed ID: 15677311
[TBL] [Abstract][Full Text] [Related]
17. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.
Shukla MN; Rose JL; Ray R; Lathrop KL; Ray A; Ray P
Am J Respir Cell Mol Biol; 2009 Jun; 40(6):643-53. PubMed ID: 18988920
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines.
Chen CL; Chou KJ; Lee PT; Chen YS; Chang TY; Hsu CY; Huang WC; Chung HM; Fang HC
Exp Cell Res; 2010 Apr; 316(7):1109-18. PubMed ID: 20202468
[TBL] [Abstract][Full Text] [Related]
20. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis.
Li Y; Yang J; Dai C; Wu C; Liu Y
J Clin Invest; 2003 Aug; 112(4):503-16. PubMed ID: 12925691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]